Efficacy of Etanercept in the Tumor Necrosis Factor Receptor–Associated Periodic Syndrome (TRAPS)

OBJECTIVE: To investigate the efficacy of etanercept in improving the symptoms and underlying inflammation in patients with the TNF receptor-associated periodic syndrome (TRAPS). METHODS: Fifteen patients with TRAPS were enrolled in a prospective, open-label, dose-escalation study. Patients recorded...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Bulua, Ariel C., Mogul, Douglas B., Aksentijevich, Ivona, Singh, Harjot, He, David, Muenz, Larry, Ward, Michael M., Yarboro, Cheryl, Kastner, Daniel L., Siegel, Richard M., Hull, Keith M.
Format: Artigo
Langue:Inglês
Publié: 2012
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3882089/
https://ncbi.nlm.nih.gov/pubmed/22006113
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/art.33416
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires